首页> 外文期刊>CNS Neuroscience & Therapeutics >RESEARCH: Zopiclone (Cyclopyrrolone): A Novel Hypnosedative; Hypnosedation Caused by Zopiclone Does Not Impair Memory-Learning in Albino Mice
【24h】

RESEARCH: Zopiclone (Cyclopyrrolone): A Novel Hypnosedative; Hypnosedation Caused by Zopiclone Does Not Impair Memory-Learning in Albino Mice

机译:研究:佐匹克隆(环吡咯烷酮):一种新型的催眠镇静药。 Zopiclone引起的催眠作用不会损害白化小鼠的记忆学习。

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: To evaluate hypnosedative action of Zopiclone by using animal models for hypnosis and sedation (anxiolysis); and to further evaluate whether this hypnosedation impairs memory-learning in albino mice like conventional hypnosedatives. Methods: For evaluation of hypnosedation, following experiments were performed in albino mice: (1) righting reflex test, (2) pentobarbitone sleeping time potentiation, (3) open field apparatus behavior, and (4) elevated plus maze performance. For evaluation of effects on impairment of memory-learning, elevated plus maze retention test was performed in albino mice. Results: Zopiclone (7.5 mg/kg p.o.) did not inhibit the righting reflex. Significant (P < 0.001) potentiation of pentobarbitone sleeping time and increase in exploration in open field apparatus was observed. Elevated plus maze performance also showed significant (P < 0.01) increase in number of entries to open arm at the same time significant (P < 0.02) increase in time spent in open arm was observed. Elevated plus maze retention test showed significant (P < 0.01) increase in transfer latency on second day of experiment. Conclusions: Zopiclone (7.5 mg/kg p.o.) has selective hypnosedative activity but not CNS-depressant activity similar to BZDs. Hypnosedative action of Zopiclone does not impair memory-learning in albino mice like conventional hypnosedatives.
机译:目的:使用动物模型进行催眠和镇静(抗焦虑),评估佐匹克隆的催眠作用;并进一步评估这种催眠作用是否会像传统催眠药一样损害白化病小鼠的记忆学习。方法:为了评估催眠作用,在白化病小鼠中进行了以下实验:(1)扶正反射测试;(2)戊巴比妥睡眠时间增强;(3)野外仪器行为;以及(4)高迷迷宫性能。为了评估对记忆学习障碍的影响,在白化病小鼠中进行了升高的迷宫保留测试。结果:佐匹克隆(7.5 mg / kg p.o.)不会抑制扶正反射。在野外仪器中观察到戊巴比妥睡眠时间的显着增强(P <0.001)和探查增加。升高的迷宫性能也显示打开手臂的条目数量显着增加(P <0.01),同时观察到打开手臂所花费的时间显着(P <0.02)增加。升高的迷宫保留测试显示,实验第二天的转移潜伏期显着增加(P <0.01)。结论:佐匹克隆(7.5 mg / kg p.o.)具有选择性的催眠镇静活性,但不具有与BZD相似的CNS抑制活性。佐匹克隆的催眠作用不会像传统催眠药一样损害白化病小鼠的记忆学习。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号